Metrics to compare | 000661 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship000661PeersSector | |
|---|---|---|---|---|
P/E Ratio | −84.0x | 16.0x | −0.4x | |
PEG Ratio | 0.70 | 0.52 | 0.00 | |
Price/Book | 1.3x | 2.2x | 2.6x | |
Price / LTM Sales | 2.7x | 2.7x | 3.0x | |
Upside (Analyst Target) | 39.4% | 35.0% | 48.7% | |
Fair Value Upside | Unlock | 14.6% | 7.0% | Unlock |
Changchun High-Tech Industry (Group) Co., Ltd., together with its subsidiaries, researches, develops, manufactures, and sells biopharmaceuticals and traditional Chinese medicines products in China. The company offers recombinant human growth hormone injection; recombinant human follicle stimulating hormone for injection; herpes zoster vaccines; live attenuated varicella vaccine; freeze-dried nasal spray live attenuated influenza; xueshuanxinmaining tablet; and yinhuamiyanling tablet. It also develops real estate properties. The company was founded in 1993 and is based in Changchun, China.